Viewing Study NCT02544958


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2025-12-31 @ 2:20 AM
Study NCT ID: NCT02544958
Status: UNKNOWN
Last Update Posted: 2016-06-01
First Post: 2015-09-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Er:YAG Laser for Treatment of Enlarged Pores
Sponsor: Mahidol University
Organization:

Study Overview

Official Title: The Efficacy and Safety of Erbium:Yttrium Aluminum Garnet Laser for Treatment of Enlarged Pores: A Pilot Study
Status: UNKNOWN
Status Verified Date: 2016-05
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To investigate the efficacy of Erbium:Yttrium aluminum garnet laser (Er:YAG) in the treatment of enlarged pores.
Detailed Description: * Enlarged pores are caused by multifactorial factors such as sex, genetics, aging, etc.
* The gold of the treatment is to recollagenesis of the dermis and resurfacing of the epidermis.
* Modalities that have been proved on their efficacy for enlarged pores treatment included topical retinoic acid, chemical peeling, intense pulsed light, radiofrequency device, laser such as Q-switched and Long Pulsed Neodymium-Doped Yttrium-Aluminum-Garnet (Nd:YAG) 1,064nm, Long pulse duration pulsed dye laser 595nm, etc.
* Er:YAG laser is an ablative laser which creates both recollagenesis and resurfacing. It ha been proved to be safe and effective in the treatment of atrophic acne scar.
* However, the efficacy of this laser for enlarged treatment has not yet been established.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: